What is ProtoLytic?
ProtoLytic, LLC operates at the intersection of artificial intelligence and healthcare administration, providing sophisticated software solutions designed to streamline complex medical claims workflows. The company's flagship offerings, Proto-Link and UR Express, serve as critical infrastructure for healthcare providers and insurance entities. Proto-Link functions as a high-performance analytics engine, synthesizing vast datasets to provide actionable recommendations aligned with intricate medical treatment and reimbursement protocols. Complementing this, UR Express automates the labor-intensive processes of medical insurance case management and utilization review. By offering both cloud-based accessibility and seamless integration capabilities, ProtoLytic addresses the urgent industry demand for increased efficiency, reduced administrative overhead, and improved accuracy in insurance adjudication.
How much funding has ProtoLytic raised?
ProtoLytic has raised a total of $315K across 2 funding rounds:
Debt
$150K
Debt
$165K
Debt (2020): $150K with participation from PPP
Debt (2021): $165K led by PPP
Key Investors in ProtoLytic
PPP
Public-Private Partnership
What's next for ProtoLytic?
With this recent capital deployment, ProtoLytic is poised to transition into a phase of aggressive market expansion and product refinement. The company's strategic roadmap likely involves enhancing the predictive capabilities of its AI engine to further reduce denial rates and optimize reimbursement cycles for its enterprise clients. As the healthcare industry continues to grapple with rising administrative costs, ProtoLytic's focus on automating utilization review and claims management positions it as a vital partner for organizations seeking to modernize their back-office operations. Future growth will likely be driven by deeper integration into existing electronic health record systems and the expansion of its cloud-based service offerings to capture a larger share of the insurance technology market.
See full ProtoLytic company page
